SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-006836
Filing Date
2023-06-27
Accepted
2023-06-27 13:41:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 29532
2 filename2.txt TEXT-EXTRACT 4528
  Complete submission text file 0000000000-23-006836.txt   45954
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filed for) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations